Previous 10 | Next 10 |
Alkermes Appoints Caroline J. Loew, Ph.D., as Chief Executive Officer Designate of Mural Oncology plc PR Newswire — Dr. Loew to Assume New Leadership Role Upon Completion of the Planned Separation of Alkermes' Oncology Business — — Planned Separati...
Alkermes to Participate in Two Upcoming Investor Conferences PR Newswire DUBLIN , May 31, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in fireside chats at two upcoming investor conferences. Jefferies...
Alkermes Files Definitive Proxy Statement and Issues Letter to Shareholders Detailing Business Execution That Has Driven Strong Performance and Delivered Shareholder Value PR Newswire Company Has Outperformed Peers and Relevant Indices Since Unveiling its December 2020 Val...
Alkermes Highlights Data From Psychiatry Portfolio at Spring 2023 Scientific Conferences PR Newswire ̶ Clinical and Patient Experience Research Delivers Insights into Treatment for People Living with Schizophrenia or Bipolar I Disorder ̶ DUB...
Alkermes Announces Two Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire – Trial-in-Progress Posters From ARTISTRY-6 and ARTISTRY-7 Clinical Trials to be Presented – DUBLIN ...
2023-05-08 18:00:12 ET Alkermes' ( NASDAQ: ALKS ) board said that they declined to endorse any of Sarissa Capital Management's three nominees after conducting interviews. The board said it is hoping to find a resolution that would avoid a contested election and proxy battle. ...
Alkermes Files Preliminary Proxy Statement and Provides Update on Annual Director Nomination Process PR Newswire DUBLIN , May 8, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today filed its preliminary proxy statement with the U.S. Securities and Exchange Com...
NORTHAMPTON, MA / ACCESSWIRE / May 8, 2023 / Alkermes Alkermes is proud to be selected as a 2023 Top 100 Companies Leading in Wellbeing by Ibec ! This recognition acknowledges companies in Ireland who are leading the way in supporting employee wellbeing. Alkermes has been listed as part of thi...
NORTHAMPTON, MA / ACCESSWIRE / May 4, 2023 / Alkermes' Athlone site was recently shortlisted for gradireland's 17th annual Graduate Recruitment Awards! This award recognizes outstanding graduate intake programs across Ireland. About Alkermes Alkermes plc is a fully-integrated, global biophar...
NORTHAMPTON, MA / ACCESSWIRE / May 2, 2023 / Alkermes Athlone site recently received a 2023 award in the Life Sciences category at Ireland's 2023 Health & Safety Excellence Awards. This recognition is a testament to our employees' focus on building a culture of safety and risk management in ...
News, Short Squeeze, Breakout and More Instantly...
Alkermes to Report Second Quarter Financial Results on July 24, 2024 PR Newswire DUBLIN , July 17, 2024 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET ( 1:00 p.m. BST ) on Wednesday, ...
2024-06-29 16:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-19 17:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...